Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

GENTAMYCIN SULFATE

Closed
SPE2DP-26-T-3496Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract outlines the procurement of Gentamycin Sulfate, Betamethasone Valerate, and Clotrimazole otic ointment, branded as OTOMAX, intended for veterinary use specifically to treat canines suffering from acute and chronic otitis. The product is supplied in packages containing twelve 15-gram tubes, with each tube formulated to contain 3 mg gentamycin base, 1 mg betamethasone valerate, and 10 mg clotrimazole. Storage conditions require the product to be kept between 2 to 25 degrees Celsius. The ointment is regulated by the FDA and must be properly marked in accordance with the latest medical marking standards, with specific packaging and technical quality requirements dictated by DLA standards. The contract specifies a unit of issue as a package of 12 tubes, with a shelf life of 24 months which is non-extendable. Delivery is set at 89 days after order, FOB destination, with inspection and acceptance also occurring at the destination. The contract lists multiple authorized distributors including Henry Schein, Patterson Veterinary Supply, and Covetrus North America. Bidders must provide detailed contact and product information for verification, with referral to a product specialist required prior to procurement. This acquisition is managed under Department of Defense medical supply protocols, with emphasis on compliance to the DLA master list of technical and quality requirements and federal acquisition standards.

General Info

Procurement of OTOMAX ointment for canine otitis; 12-tube packages, 24-month shelf life, FDA-regulated.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3496 Medical Supply Chain Pharma FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Office AddressUS
Contacts

Full Description

Show more
GENTAMYCIN SULFATE
GENTAMYCIN SULFATE, BETAMETHASONE VALERATE AND CLOTRIMAZOLE OTIC
OINTMENT, VETERINARY.
.
OTOMAX OINTMENT<(>,<)> TWELVE 15GM TUBES; BROAD SPECTRUM ANTIBIOTIC;
15 GM TUBE; EQUIVALENT TO 3 MG GENTAMYCLIN BASE<(>,<)>
BETAMETHASONE VALERATE EQUIVALENT TO 1 MG AND 10 MG
CLOTRIMAZOLE; USED TO TREAT CANINES WITH ACUTE & CHRONIC OITITIS.
.
UNIT OF ISSUE: PACKAGE (PG) OF 12EA.
.
STORE BETWEEN 2-25 DEGREES C (36-77 DEG F).
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 PG = 12 EA
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
.
..
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
HENRY SCHEIN, INC. 0NUS8 P/N OTOMAX PATTERSON VETERINARY SUPPLY, INC. 3G5T7 P/N 07-807-3864 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 007209
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3496
SECTION B
PR: 7016876683 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016876683 0001 PG 1.000
NSN/MATERIAL:6509015304283
DELIVERY (IN DAYS):0089
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6509-01-530-4283 Quantity: 1 PG Purchase Request: 7016876683QTY: 1 Delivery: 89 days ADO